Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vijay Kumar Kuchroo, Ph.D.

Co-Author

This page shows the publications co-authored by Vijay Kuchroo and David Hafler.
Connection Strength

2.777
  1. TIMs: central regulators of immune responses. J Exp Med. 2008 Nov 24; 205(12):2699-701.
    View in: PubMed
    Score: 0.419
  2. Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells. J Clin Invest. 2015 Nov 02; 125(11):4212-22.
    View in: PubMed
    Score: 0.169
  3. Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cells. J Clin Invest. 2014 Jun; 124(6):2513-22.
    View in: PubMed
    Score: 0.153
  4. Small-molecule ROR?t antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms. Immunity. 2014 Apr 17; 40(4):477-89.
    View in: PubMed
    Score: 0.153
  5. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity. 2014 Apr 17; 40(4):569-81.
    View in: PubMed
    Score: 0.153
  6. The CD226/CD155 interaction regulates the proinflammatory (Th1/Th17)/anti-inflammatory (Th2) balance in humans. J Immunol. 2013 Oct 01; 191(7):3673-80.
    View in: PubMed
    Score: 0.146
  7. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012 Oct; 13(10):991-9.
    View in: PubMed
    Score: 0.137
  8. The TIGIT/CD226 axis regulates human T cell function. J Immunol. 2012 Apr 15; 188(8):3869-75.
    View in: PubMed
    Score: 0.132
  9. TGF-beta induces IL-9 production from human Th17 cells. J Immunol. 2010 Jul 01; 185(1):46-54.
    View in: PubMed
    Score: 0.116
  10. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur J Immunol. 2009 Sep; 39(9):2492-501.
    View in: PubMed
    Score: 0.111
  11. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood. 2009 Apr 30; 113(18):4240-9.
    View in: PubMed
    Score: 0.106
  12. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature. 2008 Jul 17; 454(7202):350-2.
    View in: PubMed
    Score: 0.101
  13. TIM-4 expressed on APCs induces T cell expansion and survival. J Immunol. 2008 Apr 01; 180(7):4706-13.
    View in: PubMed
    Score: 0.100
  14. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science. 2007 Nov 16; 318(5853):1141-3.
    View in: PubMed
    Score: 0.098
  15. Dysregulated T cell expression of TIM3 in multiple sclerosis. J Exp Med. 2006 Jun 12; 203(6):1413-8.
    View in: PubMed
    Score: 0.088
  16. Cross-reactive TCR responses to self antigens presented by different MHC class II molecules. J Immunol. 2004 Aug 01; 173(3):1689-98.
    View in: PubMed
    Score: 0.078
  17. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity. 2004 May; 20(5):563-75.
    View in: PubMed
    Score: 0.077
  18. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4. J Immunol. 1997 Nov 15; 159(10):4799-805.
    View in: PubMed
    Score: 0.049
  19. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors. J Immunol. 1997 Mar 01; 158(5):2025-34.
    View in: PubMed
    Score: 0.047
  20. Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones. Proc Natl Acad Sci U S A. 1996 Dec 24; 93(26):15317-22.
    View in: PubMed
    Score: 0.046
  21. TCR usage in human and experimental demyelinating disease. Immunol Today. 1996 Apr; 17(4):152-9.
    View in: PubMed
    Score: 0.044
  22. Role of Th1 and Th2 cells in neurologic disorders. Chem Immunol. 1996; 63:171-86.
    View in: PubMed
    Score: 0.043
  23. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J Immunol. 1995 Jul 15; 155(2):982-92.
    View in: PubMed
    Score: 0.042
  24. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature. 2015 Feb 19; 518(7539):337-43.
    View in: PubMed
    Score: 0.040
  25. T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR V beta 8.2 transgenic mice. J Exp Med. 1994 May 01; 179(5):1659-64.
    View in: PubMed
    Score: 0.038
  26. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med. 2007 Feb; 13(2):211-7.
    View in: PubMed
    Score: 0.023
  27. High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model. J Immunol. 2005 Feb 15; 174(4):1938-46.
    View in: PubMed
    Score: 0.020
  28. Disease-related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis. Eur J Immunol. 2004 Jul; 34(7):1839-48.
    View in: PubMed
    Score: 0.019
  29. T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol. 2004 Jun 01; 172(11):7169-76.
    View in: PubMed
    Score: 0.019
  30. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994 Aug 26; 265(5176):1237-40.
    View in: PubMed
    Score: 0.010
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.